Differential induction of pro- and anti-inflammatory cytokines in whole blood by bacteria: effects of antibiotic treatment

Antimicrob Agents Chemother. 1997 Jul;41(7):1439-43. doi: 10.1128/AAC.41.7.1439.

Abstract

The in vitro production of interleukin-1beta (IL-1beta), IL-6, and the IL-1 receptor antagonist (IL-1ra) in whole blood upon stimulation with different bacterial strains was measured to study the possible relationship between disease severity and the cytokine-inducing capacities of these strains. Escherichia coli, Neisseria meningitidis, Neisseria gonorrhoeae, Bacteroides fragilis, Capnocytophaga canimorsus, Staphylococcus aureus, Enterococcus faecalis, Streptococcus pneumoniae, and Streptococcus pyogenes induced the cytokines IL-1beta, IL-6, and IL-1ra. Gram-negative bacteria induced significantly higher levels of proinflammatory cytokine production than gram-positive bacteria. These differences were less pronounced for the anti-inflammatory cytokine IL-1ra. In addition, blood was stimulated with E. coli killed by different antibiotics to study the effect of the antibiotics on the cytokine-inducing capacity of the bacterial culture. E. coli treated with cefuroxime and gentamicin induced higher levels of IL-1beta and IL-6 production but levels of IL-1ra production similar to that of heat-killed E. coli. In contrast, ciprofloxacin- and imipenem-cilastatin-mediated killing showed a decreased or similar level of induction of cytokine production as compared to that by heat-killed E. coli; polymyxin B decreased the level of production of the cytokines.

Publication types

  • Comparative Study

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Bacteria / drug effects*
  • Bacteria / metabolism
  • Escherichia coli / drug effects
  • Gram-Negative Bacteria / drug effects
  • Gram-Negative Bacteria / metabolism
  • Gram-Positive Bacteria / drug effects
  • Gram-Positive Bacteria / metabolism
  • Humans
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1 / biosynthesis*
  • Interleukin-1 / blood
  • Interleukin-6 / biosynthesis*
  • Interleukin-6 / blood
  • Lipopolysaccharides / pharmacology
  • Receptors, Interleukin-1 / antagonists & inhibitors*
  • Sialoglycoproteins / biosynthesis*
  • Sialoglycoproteins / blood
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • IL1RN protein, human
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1
  • Interleukin-6
  • Lipopolysaccharides
  • Receptors, Interleukin-1
  • Sialoglycoproteins